Market revenue in 2023 | USD 125.0 million |
Market revenue in 2030 | USD 199.7 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Attenuated vaccine |
Fastest growing segment | DNA Vaccines |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines |
Key market players worldwide | Lonza Group Ltd, FUJIFILM Holdings Corp, Merck KGaA, Catalent Inc, Icon PLC, Syngene, Curia, Ajinomoto Co Inc, IDT Biologika |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine contract manufacturing market will help companies and investors design strategic landscapes.
Attenuated vaccine was the largest segment with a revenue share of 30.4% in 2023. Horizon Databook has segmented the South Korea vaccine contract manufacturing market based on attenuated vaccine, inactivated vaccine, subunit vaccines, toxoid vaccines, dna vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
The South Korean government has implemented various regulations and guidelines to ensure the safety of vaccines, such as the GMP and the Korean Pharmacopoeia. These guidelines provide recommendations for the manufacturing, testing, & storing vaccines to prevent contamination and ensure their effectiveness.
Overall, the vaccine contract manufacturing market in South Korea is expected to grow in the coming years, driven by the increasing demand for vaccines and the government's initiatives to support drug development companies.
The market is highly competitive, with several players offering a wide range of services and products, and it is likely to continue to attract local and international companies.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea vaccine contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into South Korea vaccine contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account